Kristina E. Aaltonen

Medicon Village
Lund, M 22381, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

NeoCircle: pre- and post-operative circulating tumor DNA dynamics predicts survival in neoadjuvant-treated early breast cancer.

NeoCircle: pre- and post-operative circulating tumor DNA dynamics predicts survival in neoadjuvant-treated early breast cancer.

Journal: EMBO molecular medicine

Published: November 10, 2025

GSPT1-specific protein degradation is effective in preclinical models of chemoresistant MYCN-amplified neuroblastoma.

GSPT1-specific protein degradation is effective in preclinical models of chemoresistant MYCN-amplified neuroblastoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: August 11, 2025

Evaluation of TRPA1 as a Therapeutic Target in MYCN-Amplified Neuroblastoma.

Evaluation of TRPA1 as a Therapeutic Target in MYCN-Amplified Neuroblastoma.

Journal: Pediatric blood & cancer

Published: March 05, 2025

Targeted ferroptosis induction enhances chemotherapy efficacy in chemoresistant neuroblastoma.

Targeted ferroptosis induction enhances chemotherapy efficacy in chemoresistant neuroblastoma.

Journal: NPJ precision oncology

Published: December 30, 2024

Repurposing statins and phenothiazines to treat chemoresistant neuroblastoma.

Repurposing statins and phenothiazines to treat chemoresistant neuroblastoma.

Journal: EMBO molecular medicine

Published: December 04, 2024

Gene expression in metastatic breast cancer-patterns in primary tumors and metastatic tissue with prognostic potential.

Gene expression in metastatic breast cancer-patterns in primary tumors and metastatic tissue with prognostic potential.

Journal: Frontiers in molecular biosciences

Published: November 24, 2023

Macrophage infiltration promotes regrowth in MYCN-amplified neuroblastoma after chemotherapy.

Macrophage infiltration promotes regrowth in MYCN-amplified neuroblastoma after chemotherapy.

Journal: Oncoimmunology

Published: March 06, 2023

Patient-derived models: Advanced tools for precision medicine in neuroblastoma.

Patient-derived models: Advanced tools for precision medicine in neuroblastoma.

Journal: Frontiers in oncology

Published: October 31, 2022

Clinically relevant treatment of PDX models reveals patterns of neuroblastoma chemoresistance.

Clinically relevant treatment of PDX models reveals patterns of neuroblastoma chemoresistance.

Journal: Science advances

Published: October 28, 2022

Engineering human mini-bones for the standardized modeling of healthy hematopoiesis, leukemia, and solid tumor metastasis.

Engineering human mini-bones for the standardized modeling of healthy hematopoiesis, leukemia, and solid tumor metastasis.

Journal: Science translational medicine

Published: October 12, 2022

Early evolutionary branching across spatial domains predisposes to clonal replacement under chemotherapy in neuroblastoma.

Early evolutionary branching across spatial domains predisposes to clonal replacement under chemotherapy in neuroblastoma.

Journal: Nature communications

Published: October 03, 2022

Anti-tumor effects of rigosertib in high-risk neuroblastoma.

Anti-tumor effects of rigosertib in high-risk neuroblastoma.

Journal: Translational oncology

Published: April 21, 2021

Showing 1-12 of 32

Last Updated: 09/26/2026